SBC Medical Group Holdings Incorporated (SBC) Revenue History
Annual and quarterly revenue from 2022 to present
SBC Revenue Over Time (2022–2025)
SBC Revenue Growth History
2 of 3 years with positive growth- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- +11.1%
- FY2024 revenue growth
- +6.1%
- FY2025 revenue growth
- -15.5%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $43.1M | -9.0% |
| Q4 2025 | $39.6M | -10.9% |
| Q3 2025 | $43.4M | -18.3% |
| Q2 2025 | $43.4M | -18.3% |
| Q1 2025 | $47.3M | -13.6% |
| Q4 2024 | $44.4M | -28.8% |
| Q3 2024 | $53.1M | +12.3% |
| Q2 2024 | $53.1M | +29.5% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
SBC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
SBC Revenue Analysis (2022–2025)
Current Revenue & Growth
As of June 29, 2026, SBC Medical Group Holdings Incorporated (SBC) generated trailing twelve-month (TTM) revenue of $169.3 million, reflecting moderate decline in growth of -9.0% year-over-year. The most recent quarter (Q1 2026) recorded $43.1 million in revenue, up 8.8% sequentially.
Historical Growth Trajectory
SBC's historical revenue data shows a 3-year CAGR of -0.1%. SBC Medical Group Holdings Incorporated's highest annual revenue of $205.4 million was recorded in 2024.
Revenue by Segment
SBC's revenue is primarily driven by Procurement Services (32%), Franchising (26%), and Management Services (17%). The diversified mix across segments reduces dependence on any single product line, which can support more resilient revenue in downturns.
Peer Comparison
Compared to Industrials sector peers — including SKIN (-8.2% YoY), INMD (-4.5% YoY), and SSKN (-8.5% YoY) — SBC has underperformed the peer group in revenue growth. Compare SBC vs SKIN →
SBC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SBCCurrent | $169M | -9.0% | - | 38.9% | |
 SKIN | $301M | -8.2% | +20.4% | -6.9% | |
 INMD | $370M | -4.5% | +12.4% | 23.0% | |
 SSKN | $31M | -8.5% | +5.9% | -19.0% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 LASE | $8M | +40.4% | +29.7% | -115.5% |
SBC Historical Revenue Data (2022–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $173.6M | -15.5% | $127.3M | 73.3% | $67.5M | 38.9% |
| 2024 | $205.4M | +6.1% | $156.1M | 76.0% | $70.3M | 34.2% |
| 2023 | $193.5M | +11.1% | $137.3M | 70.9% | $70.7M | 36.5% |
| 2022 | $174.2M | - | $114.8M | 65.9% | $20.1M | 11.6% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SBC — Frequently Asked Questions
Quick answers to the most common questions about buying SBC stock.
Is SBC's revenue growth accelerating or slowing?
SBC revenue is declining -9.0% year-over-year. TTM revenue fell to $169M, contrasting with the 5-year CAGR of N/A. The reversal reflects either macro headwinds or company-specific challenges.
What is SBC's revenue history from 2022 to 2026?
SBC Medical Group Holdings Incorporated (SBC) revenue history spans 2022 to 2026. TTM revenue as of 2026 is $169M, growing at -9.0% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SBC's long-term revenue growth rate (CAGR)?
SBC Medical Group Holdings Incorporated's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -9.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SBC.
Why does SBC's quarterly revenue fluctuate?
SBC quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. SBC Medical Group Holdings Incorporated's revenue data from 2022 to 2026 shows full historical quarterly detail on this page.
How is SBC's revenue distributed by segment?
SBC reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SBC's revenue compare to industry peers?
SBC Medical Group Holdings Incorporated (SBC) with TTM revenue of $169M and -9.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.